Author:
Pang K. Sandy,Peter Raimund M.,Rodrigues A. David
Reference127 articles.
1. Akita H, Suzuki H and Sugiyama Y (2001) Sinusoidal efflux of taurocholate is enhanced in Mrp2-deficient rat liver. Pharm Res 18:1119–1125.
2. Allen JD, Brinkhuis RF, van Deemter L, Wijnholds J and Schinkel AH (2000) Extensive contribution of the multidrug transporters P-glycoprotein and Mrp1 to basal drug resistance. Cancer Res 60:5761–5766.
3. Annaert P, Turncliff RZ, Booth CL, Thakker DR and Brouwer KLR (2001) P-Glycoprotein-mediated in vitro biliary excretion in sandwich-cultured rat hepatocytes. Drug Metab Dispos 29:1277–1283.
4. Badhan R, Penny J, Galetin A, and Houston JB (2009) Methodology for development of a physiological model incorporating CYP3A and P-glycoprotein for the prediction of intestinal drug absorption. J Pharm Sci 98:2180–2197.
5. Barter ZE. Bayliss MK, Beaune PH, Boobis AR, Carlie DJ, Edwards RJ, Houston JB, Lake BG, Lipscomb JC, Pelkonen OR, Tucker GT and Rostami-Hodjegan A (2007) Scaling factors for the extrapolation of in vivo metabolic drug clearance from in vitro data: reaching a consensus on values on human microsomal protein and hepatocellurity per gram of liver. Curr Drug Metab 8:33–45.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献